2019
DOI: 10.1016/j.msard.2019.01.049
|View full text |Cite
|
Sign up to set email alerts
|

Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
40
1
4

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 72 publications
(56 citation statements)
references
References 29 publications
9
40
1
4
Order By: Relevance
“…Our assessment further underlines this opinion, as we have shown that the less evaluated, yet frequently prevalent psychological burdens of the disease (particularly depression and fatigue) are the main determinants of the self‐reported well‐being of PwMS. We have confirmed other studies' findings (Yalachkov et al, ), that fatigue and depression are the main determinants of MS patients' HRQoL not only at disease onset, as previously shown (Nourbakhsh, Julian, & Waubant, ; when one would expect a patient to have a drop in their HRQoL, and become burdened with depression, after being diagnosed with a lifelong, degenerative disease), but years after the diagnosis as well. Therefore the evaluation and treatment of PwMS should be conducted on a much broader spectrum than regular physical and MRI examinations, even in the youngest population (Rainone et al, ), a pre‐emptive approach is proposed.…”
Section: Resultssupporting
confidence: 92%
“…Our assessment further underlines this opinion, as we have shown that the less evaluated, yet frequently prevalent psychological burdens of the disease (particularly depression and fatigue) are the main determinants of the self‐reported well‐being of PwMS. We have confirmed other studies' findings (Yalachkov et al, ), that fatigue and depression are the main determinants of MS patients' HRQoL not only at disease onset, as previously shown (Nourbakhsh, Julian, & Waubant, ; when one would expect a patient to have a drop in their HRQoL, and become burdened with depression, after being diagnosed with a lifelong, degenerative disease), but years after the diagnosis as well. Therefore the evaluation and treatment of PwMS should be conducted on a much broader spectrum than regular physical and MRI examinations, even in the youngest population (Rainone et al, ), a pre‐emptive approach is proposed.…”
Section: Resultssupporting
confidence: 92%
“…These are emotions related to depression. Depression and psychological distress are factors that have a significant impact on the MS patients' QoL [22].…”
Section: Discussionmentioning
confidence: 99%
“…Some studies focused on the impact of certain intervention on the MS patients' QoL, for example, aerobic training on fitness [5,13,14], exercise and physiotherapy [15], disease-modifying drugs [16], and diet [17], or they attempt to evaluate the agreement levels between neurologists and patient's perception of QoL [18]. Furthermore, some studies analyzed the connections among the MS patients' QoL, tiredness, depression, disability [19][20][21][22], selfperceived limitations [23], cognitive impairment [10], or social support [24]. Factors that impact the QoL were the focus of the work of Lobentanz et al [9], Berrigan et al [25], and Yamout et al [26].…”
Section: Introductionmentioning
confidence: 99%
“…La fatiga y la alteración en el estado de ánimo se han relacionado con alteración del funcionamiento cognitivo de las personas con EM (7,13,28,29) . La presencia de síntomas sensitivos y fatiga, generan un impacto negativo en actividades de la vida cotidiana, dado por la disminución en la sensación de vitalidad durante el día y empeoramiento de la función física, lo que se refleja en el deterioro de la CV e incremento de ausentismo laboral (8,12,(30)(31)(32) .…”
Section: Discussionunclassified
“…Se encontró que el 90% de los pacientes del estudio tuvieron riesgo leve o moderado de depresión evaluado con el test de Zung. De acuerdo con Olascoaga (13) , la presencia de factores psicológicos afecta de manera negativa la CV, por incremento en niveles de fatiga, disfunción física, incremento de dolor, alteraciones cognitivas y trastornos del sueño, que pueden reflejarse la falta de adherencia al tratamiento y deterioro CV de las personas con EM, que podría desencadenar un peor pronóstico (12,(32)(33)(34)(35)(36) .…”
Section: Discussionunclassified